Marshall Wace North America’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Marshall Wace North America’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$296K	Buy	+9,763	New	+$269K	0.01%	599

Other funds holding NPSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace North America's NPSP Position: Q4 2013 in Review

Marshall Wace North America opened a new position in NPS PHARMACEUTICALS INC (NPSP) in Q4 2013: 9,763 shares worth $296K. The stake represents 0.01% of the portfolio and ranks #599 among its holdings.

191 funds tracked by Wall St. Rank hold NPSP as of Q4 2013.

Marshall Wace North America held 9,763 shares of NPS PHARMACEUTICALS INC worth $296K as of Q4 2013.
NPS PHARMACEUTICALS INC was a new Marshall Wace North America position in Q4 2013.
NPS PHARMACEUTICALS INC made up 0.01% of Marshall Wace North America's portfolio in Q4 2013, its #599 holding.
191 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2013.

Based on Marshall Wace North America's 13F filing for Q4 2013, filed 14 Feb 2014.